Biovitrum

Contact
biovitrum.com
+4686972000

Biovitrum AB

Berzelius väg 8
112 76 Stockholm
Sweden
+4686972000
biovitrum.com
Contact
Profile Products News
Contact

About Biovitrum

Biovitrum is one of the largest biopharma companies in Europe. With operations in Sweden and in the UK Biovitrum conducts research and develops pharmaceuticals for unmet medical needs both for conditions that affect smaller patient populations and for common diseases. Expertise in both biopharmaceuticals and small molecules.

Read more about Biovitrum
Facts about Biovitrum
  • Focus : Manufacturer
  • Industry : Pharma

Product portfolio of Biovitrum

Product portfolio

Show all

News about Biovitrum

Biovitrum

26-Jan-2010 | business & finance

Merger of Biovitrum and Swedish Orphan

Biovitrum and Swedish Orphan have combined forming Swedish Orphan Biovitrum. The mission of the new company is to develop and make available orphan drugs ...

Read news
Biovitrum

23-Dec-2009 | business & finance

Biovitrum Sells Obesity Program to AstraZeneca

Biovitrum AB announced that AstraZeneca has acquired all of Biovitrum’s rights to its leptin modulator program aimed at treating obesity. Biovitrum will ...

Read news
Biovitrum

17-Dec-2009 | research and development

Biovitrum Advances Novel Factor VIII Long-Acting Hemophilia A Therapy into Clinical Trials

Biovitrum AB announced that the first patient was dosed in a phase I/IIa study of its long-acting fully-recombinant Factor VIII Fc fusion (rFVIIIFc) ...

Read news
Biovitrum

27-Nov-2009 | research and development

Kiobrina shows positive phase II results in preterm infants

Biovitrum AB announced that the first of two clinical phase II studies, designed to together show proof of concept of Kiobrina(TM) (rhBSSL) in preterm ...

Read news
Biovitrum

25-Nov-2009 | business & finance

Biovitrum Completes Divestiture of Cambridge Biotechnology

Biovitrum AB announced that it has completed the divestiture of its wholly-owned subsidiary Cambridge Biotechnology Ltd (CBT), and the sale of certain drug ...

Read news
Biovitrum

21-Oct-2009 | research and development

Biogen Idec and Biovitrum Announce Decision to Advance Long-Acting Hemophilia B Therapy into a Registrational Trial

Biogen Idec and Biovitrum AB announced that they plan to advance the companies' long-acting, fully-recombinant Factor IX Fc fusion protein (rFIXFc) into a ...

Read news
Biovitrum

24-Jun-2009 | business & finance

Biovitrum Transfers Two Metabolic Disease Projects to iNovacia

Biovitrum AB and iNovacia AB announced an agreement to transfer the preclinical GPR 119 and SCD-1 projects from Biovitrum to iNovacia. The agreement ...

Read news
Biovitrum

19-Mar-2009 | business & finance

Biovitrum enters agreement with Karolinska Development

Leukemia project to be pursued in a jointly owned project company

Read news
Show more news about Biovitrum

Here you will find Biovitrum AB